Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres^® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis.

ABSTRACT:

Background

Drug-eluting embolic transarterial chemoembolization (DEE-TACE) is an advance in TACE technique. However, at present there is insufficient evidence to support that DEE-TACE is superior to conventional TACE (cTACE) for hepatocellular carcinoma (HCC). The aim of this meta-analysis is to evaluate the efficacy and safety of TACE with CalliSpheres^® microspheres (CSM-TACE) compared with cTACE in patients with HCC.

Data sources

PubMed, Embase, Web of Science, CNKI and Wanfang Databases were searched to identify relevant articles published before March 26, 2020. The data regarding treatment response, survival profile, adverse events and liver function indexes were retrieved.

Results

A total of 16 studies with 1454 HCC patients (722 treated with CSM-TACE

SUBMITTER: Liang B 

PROVIDER: S-EPMC8008112 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature